LMB:NASDAQLimbach Holdings, Inc. Analysis
Data as of 2026-04-15 - not real-time
$87.73
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Limbach Holdings (LMB) is trading at $87.73, comfortably above its 20‑day ($79.85) and 50‑day ($84.68) simple moving averages but still below the 200‑day SMA ($95.65), indicating short‑term strength within a longer‑term bearish backdrop. The MACD is bullish (line positive, histogram +1.19) and RSI sits at 60, while volume is tapering and 30‑day volatility is elevated at 52.8%, signaling a potentially choppy price action near the identified resistance of $88.23.
Fundamentally, the company posted 30% YoY revenue growth, a forward EPS of $4.96 and a forward P/E of 17.7 versus the industry average of 31.2, suggesting a growth‑oriented valuation advantage. Nevertheless, the DCF fair value of $76.3 is well below the market price, debt‑to‑equity is high at 28.5%, and the historical max drawdown exceeds 55%, highlighting valuation and balance‑sheet risks. Recent earnings disclosed record revenue and EBITDA, and a strategic pivot toward large, mission‑critical customers spurred a 3.3% price jump and underpins a consensus “buy” rating with a median target of $115, implying roughly 30% upside.
Fundamentally, the company posted 30% YoY revenue growth, a forward EPS of $4.96 and a forward P/E of 17.7 versus the industry average of 31.2, suggesting a growth‑oriented valuation advantage. Nevertheless, the DCF fair value of $76.3 is well below the market price, debt‑to‑equity is high at 28.5%, and the historical max drawdown exceeds 55%, highlighting valuation and balance‑sheet risks. Recent earnings disclosed record revenue and EBITDA, and a strategic pivot toward large, mission‑critical customers spurred a 3.3% price jump and underpins a consensus “buy” rating with a median target of $115, implying roughly 30% upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price flirting with resistance at $88.23
- Bullish MACD but decreasing volume
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 30% revenue growth and strong forward earnings outlook
- Strategic shift to mission‑critical customers
- Analyst consensus target price ~30% above current level
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- DCF fair value markedly below market price
- Elevated debt‑to‑equity and historical drawdown risk
- Sustained growth potential in the building‑systems niche
Key Metrics & Analysis
Financial Health
Revenue Growth30.10%
Profit Margin6.04%
P/E Ratio27.2
ROE22.38%
ROA8.77%
Debt/Equity28.55
P/B Ratio5.2
Op. Cash Flow$45.7M
Free Cash Flow$25.2M
Industry P/E31.2
Technical Analysis
TrendBearish
RSI60.5
Support$69.58
Resistance$88.22
MA 20$79.85
MA 50$84.68
MA 200$95.65
MACDBullish
VolumeDecreasing
Fear & Greed Index88.64
Valuation
Fair Value$76.29
Target Price$116.60
Upside/Downside32.91%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.35
Volatility52.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.